Tau-targeting therapies for Alzheimer disease
EE Congdon, EM Sigurdsson - Nature Reviews Neurology, 2018 - nature.com
Alzheimer disease (AD) is the most common form of dementia. Pathologically, AD is
characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated …
characterized by amyloid plaques and neurofibrillary tangles in the brain, with associated …
The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Alzheimer's disease (AD) is the most common form of dementia worldwide. β-amyloid
peptide (Aβ) is currently assumed to be the main cause of synaptic dysfunction and cognitive …
peptide (Aβ) is currently assumed to be the main cause of synaptic dysfunction and cognitive …
[HTML][HTML] SYK coordinates neuroprotective microglial responses in neurodegenerative disease
Recent studies have begun to reveal critical roles for the brain's professional phagocytes,
microglia, and their receptors in the control of neurotoxic amyloid beta (Aβ) and myelin …
microglia, and their receptors in the control of neurotoxic amyloid beta (Aβ) and myelin …
Hesperidin as a neuroprotective agent: a review of animal and clinical evidence
Neuroprotection is the preservation of function and networks of neural tissues from damages
caused by various agents, as well as neurodegenerative diseases such as Parkinson's …
caused by various agents, as well as neurodegenerative diseases such as Parkinson's …
Mitochondrial structure and function in human heart failure
Despite clinical and scientific advancements, heart failure is the major cause of morbidity
and mortality worldwide. Both mitochondrial dysfunction and inflammation contribute to the …
and mortality worldwide. Both mitochondrial dysfunction and inflammation contribute to the …
A phase II trial of tideglusib in Alzheimer's disease
Background: The ARGO study was a phase II, double-blind, placebo controlled, four parallel
arm trial of tideglusib in Alzheimer's disease (AD). Objective: To prove the clinical efficacy of …
arm trial of tideglusib in Alzheimer's disease (AD). Objective: To prove the clinical efficacy of …
SIRT1 and SIRT2 activity control in neurodegenerative diseases
Sirtuins are NAD+ dependent histone deacetylases (HDAC) that play a pivotal role in
neuroprotection and cellular senescence. SIRT1-7 are different homologs from sirtuins. They …
neuroprotection and cellular senescence. SIRT1-7 are different homologs from sirtuins. They …
Emerging PET radiotracers and targets for imaging of neuroinflammation in neurodegenerative diseases: outlook beyond TSPO
V Narayanaswami, K Dahl… - Molecular …, 2018 - journals.sagepub.com
The dynamic and multicellular processes of neuroinflammation are mediated by the
nonneuronal cells of the central nervous system, which include astrocytes and the brain's …
nonneuronal cells of the central nervous system, which include astrocytes and the brain's …
Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology
Clinico-pathological correlation studies and positron emission tomography amyloid imaging
studies have shown that some individuals can tolerate substantial amounts of Alzheimer's …
studies have shown that some individuals can tolerate substantial amounts of Alzheimer's …
Review on anti-alzheimer drug development: approaches, challenges and perspectives
AE Abdallah - RSC advances, 2024 - pubs.rsc.org
Alzheimer is an irreversible progressive neurodegenerative disease that causes failure of
cerebral neurons and disability of the affected person to practice normal daily life activities …
cerebral neurons and disability of the affected person to practice normal daily life activities …